What role does serendipity play in forming a multi-billion dollar targeted oncology company? And what happens when you have incentive alignment across patients, HCPs, patient advocates, researchers, and big pharma?

Keep reading to discover how serendipity, rigor, and science can lead to game-changing treatments in targeted oncology.

‍Take me to the full article >>>

‍